Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
62.4% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
22
users have liked this narrative
6
users have commented on this narrative
50
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
30.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
31
users have liked this narrative
6
users have commented on this narrative
85
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.2% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
11
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Co-Diagnostics
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Clinical Advancements And Cloud Integration Will Shape Molecular Diagnostics
Key Takeaways Expanding into high-prevalence markets with advanced diagnostic tests and digital health integration positions the company for substantial growth and competitive differentiation. Building local infrastructure and securing global health partnerships supports cost efficiency, recurring revenues, and long-term improvement in margins.
View narrative
US$5.50
FV
95.4% undervalued
intrinsic discount
186.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
4
users have followed this narrative
15 days ago
author updated this narrative
Marley Spoon Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Integrated Platform And Asset-Light Model Will Improve Efficiency
Key Takeaways Transition to an integrated platform model and refined marketing boost customer lifetime value and improve revenue growth and net margins. Cost reduction and asset-light model in U.S. enhance operational efficiency, potentially driving future earnings and improved EBITDA.
View narrative
€1.80
FV
76.1% undervalued
intrinsic discount
1.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
BioAtla
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Mec-V And ROR2-ADC Programs Will Achieve Clinical Milestones
Key Takeaways Promising results in clinical programs and strategic partnerships indicate potential for increased revenue, improved net margins, and financial stability through collaboration income. Resource realignment and reduced R&D expenses suggest better operational efficiency and net margin improvement over the next year.
View narrative
US$8.33
FV
95.5% undervalued
intrinsic discount
-21.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
15 days ago
author updated this narrative
Tortilla Mexican Grill
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Technology Investments And European Expansion Will Fuel Fast Casual Evolution
Key Takeaways Technology adoption, menu innovation, and cost management are enhancing efficiency, customer loyalty, and margins, supporting sustainable growth and operational resilience. Expansion into Europe and a growing franchise network are expected to accelerate top-line growth and drive higher-margin, asset-light revenue streams.
View narrative
UK£0.68
FV
34.8% undervalued
intrinsic discount
7.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
15 days ago
author updated this narrative
HBR Realty Empreendimentos Imobiliários
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Mogi Das Cruzes And ComVem Will Increase Rentals Despite Headwinds
Key Takeaways Strategic expansion and increased occupancy in key properties are expected to drive revenue growth and improve rental income. Asset recycling and strategic disposals are aimed at debt reduction and enhanced capital efficiency, potentially boosting earnings and net margins.
View narrative
R$11.88
FV
70.4% undervalued
intrinsic discount
30.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
15 days ago
author updated this narrative
ANGLE
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Pharma Partnerships And Liquid Biopsy Will Expand Future Markets
Key Takeaways ANGLE's unique technologies and partnerships in precision oncology position it for strong, margin-expanding revenue growth as liquid biopsy adoption accelerates. Ongoing innovation, clinical validation, and disciplined cost management enhance ANGLE's competitive strength, diversify revenues, and improve long-term profitability.
View narrative
UK£0.28
FV
79.5% undervalued
intrinsic discount
138.15%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
15 days ago
author updated this narrative
Genius Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Easing Legal Hurdles Will Unleash AI Edtech And Bitcoin Expansion
Key Takeaways Lifting of legal restrictions and legal resolutions may boost platform growth, product launches, and financial stability while lowering extraordinary costs and supporting future earnings potential. Expansion of AI-driven, personalized learning and unified edtech offerings under the Genius brand is expected to increase user engagement, recurring revenue, and global market reach.
View narrative
US$4.30
FV
73.5% undervalued
intrinsic discount
54.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
15 days ago
author updated this narrative
TPXimpact Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
UK Government Spending And AI Integration Will Redefine Digital Services
Key Takeaways Strategic focus on public sector digital transformation and strong government relationships position the company for revenue growth and improved contract quality. Integration of AI, operational streamlining, and regulatory tailwinds enhance efficiency, margin expansion, and stability of recurring revenues.
View narrative
UK£0.67
FV
69.6% undervalued
intrinsic discount
5.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
15 days ago
author updated this narrative
Inuvo
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Automation, AI And Self Serve Platform Will Drive Efficiency
Key Takeaways Strong demand and growth in Inuvo’s products and technological advancements in AI and automation are expected to drive revenue and efficiency improvements. A focus on a high-margin self-serve platform and a reverse stock split aims to enhance profitability and investor confidence, potentially boosting earnings.
View narrative
US$13.50
FV
60.8% undervalued
intrinsic discount
15.14%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
15 days ago
author updated this narrative
Value any company in seconds
Popular companies